Orthofix' BREG wins Novation deal:
This article was originally published in Clinica
BREG has won a three-year contract to supply US group purchasing organisation (GPO) Novation with its line of Polar Care cold therapy products. The agreement takes effect on January 1 2006. Huntersville, North Carolina-based BREG, which was acquired by orthopaedics group Orthofix International in 2003, reported sales of $18.0m in the Americas region for the third quarter of 2005.
You may also be interested in...
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.
South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and aims to file a US NDA for the orphan drug.